Article info
Hepatology
Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma
- Correspondence to Mark Kester, Departments of Pharmacology and of Cellular and Molecular Physiology, 500 University Drive, R130, P O Box 850, Hershey, PA 17033-0858, USA; mkester{at}psu.edu
Citation
Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma
Publication history
- Revised October 8, 2010
- Accepted November 8, 2010
- First published December 30, 2010.
Online issue publication
October 26, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.